Success Metrics

Clinical Success Rate
91.7%

Based on 11 completed trials

Completion Rate
92%(11/12)
Active Trials
5(18%)
Results Posted
27%(3 trials)
Terminated
1(4%)

Phase Distribution

Ph phase_4
6
21%
Ph early_phase_1
1
4%
Ph not_applicable
4
14%
Ph phase_2
10
36%
Ph phase_3
5
18%

Phase Distribution

1

Early Stage

10

Mid Stage

11

Late Stage

Phase Distribution26 total trials
Early Phase 1First-in-human
1(3.8%)
Phase 2Efficacy & side effects
10(38.5%)
Phase 3Large-scale testing
5(19.2%)
Phase 4Post-market surveillance
6(23.1%)
N/ANon-phased studies
4(15.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

91.7%

11 of 12 finished

Non-Completion Rate

8.3%

1 ended early

Currently Active

5

trials recruiting

Total Trials

28

all time

Status Distribution
Active(7)
Completed(11)
Terminated(1)
Other(9)

Detailed Status

Completed11
unknown9
Recruiting5
Not yet recruiting2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
28
Active
5
Success Rate
91.7%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (3.8%)
Phase 210 (38.5%)
Phase 35 (19.2%)
Phase 46 (23.1%)
N/A4 (15.4%)

Trials by Status

completed1139%
recruiting518%
terminated14%
unknown932%
not_yet_recruiting27%

Recent Activity

Clinical Trials (28)

Showing 20 of 28 trialsScroll for more
NCT06308952Phase 4

Atorvastatin Pretreatment in Cerebrovascular Events (APICES) After Flow Diverter Implantation

Recruiting
NCT06248671Phase 2

Prophylactic Treatment With Atorvastatin for Episodic Migraine.

Recruiting
NCT06199921Phase 2

ATORvastatin in Pulmonary TUBerculosis

Recruiting
NCT05028829Phase 2

Safety and Efficacy of Atorvastatin v. Placebo on HCC Risk

Recruiting
NCT04379999Early Phase 1

Atorvastatin ± Aspirin in Lynch Syndrome Syndrome

Completed
NCT05563389Phase 2

Statin Impact on Hepatic Decompensation

Completed
NCT06327451Phase 2

Evaluate the Efficacy and Safety of Atorvastatin Combined With Temozolomide in the Treatment of Glioblastoma

Recruiting
NCT05912686Phase 4

High-Dose Atorvastatin for Vascular Wall Protection in Thrombectomy Patients

Not Yet Recruiting
NCT05511766Phase 2

Allopurinol Versus Atorvastatin to Prevent Complications of Liver Cirrhosis

Unknown
NCT05049603Phase 3

A Randomized Clinical Trial to Evaluate the Effects of Atorvastatin on Graves' Orbitopathy (GO): the STAGO-2 Study

Not Yet Recruiting
NCT04943783Not Applicable

Atorvastatin in the TREATment of Intracranial Unruptured VertebroBasilar Dissecting Aneurysms

Unknown
NCT01759836Phase 2

Impact of Adjuvant Statin Therapy in Patients Who Underwent Radical Prostatectomy for Locally Advanced Prostate Cancer

Completed
NCT03956368Phase 3

Efficacy of Atorvastatin in Chronic Subdural Haematoma

Unknown
NCT03692754Phase 2

Atorvastatin in Management of Newly Diagnosed ITP

Unknown
NCT04486508Phase 3

Intermediate-dose vs Standard Prophylactic Anticoagulation and Statin vs Placebo in ICU Patients With COVID-19

Completed
NCT03966859Not Applicable

7-day Atorvastatin and Emotional Processing

Completed
NCT01341730Phase 4

The Effect of Atorvastatin and Pioglitazone on Carotid Atherosclerosis With the Use of Positron Emission Tomography-computed Tomography (PET-CT)

Terminated
NCT03051100Phase 2

Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) 180mg, Ezetimibe 10mg, and Atorvastatin 20 mg Triplet Therapy in Patients With Elevated LDL-C

Completed
NCT04151355Not Applicable

Effect of Atorvastatin on 5-Fluorouracil Induced Mucositis

Unknown
NCT02781064Phase 4

STATIN: Web-based Investigation of Side Effects

Completed

Drug Details

Intervention Type
DRUG
Total Trials
28